Anmeldung erfolgt in Kürze...
Details werden geladen...
India's weight-loss drug boom raises questions over healthcare priorities - The Economic Times
India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns about misuse for cosmetic reasons are growing. Regulators are intervening in advertising. The drugs also have side effects and can lead to weight regain. This boom is impacting pharmaceutical research priorities.
Ähnliche Seiten
India's weight-loss market grows up - The Economic Times
https://economictimes.indiatimes.com/opinion/et-editorial/indias-weight-loss-market-grows-up/articleshow/131641651.cms
Encouraging trial results for AstraZeneca's new weight-loss pill | The Manila Times
https://www.manilatimes.net/2026/06/09/world/encouraging-trial-results-for-astrazenecas-new-weight-loss-pill/2361567
Muscle growth drug ‘could reduce loss of lean tissue’ when using slimming jabs | Weight-loss drugs | The Guardian
https://www.theguardian.com/science/2026/jun/08/muscle-growth-drug-lean-body-mass-slimming-jabs
Weight loss drugs and nutrient deficiency: What nutrients are GLP-1 users lacking?
https://timesofindia.indiatimes.com/etimes/wellness/weight-loss-drugs-and-nutrient-deficiency-what-nutrients-are-glp-1-users-lacking/photostory/131292164.cmsEli Lilly’s obesity drug shows up to 30% weight loss in trial - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/eli-lillys-obesity-drug-shows-up-to-30-weight-loss-in-trial/articleshow/131249598.cms